The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Genetic alterations in breast cancer
Abstract
The etiology of breast cancer involves a complex interplay of various factors, including genetic alterations. Many studies have been devoted to the identification and characterization of mutations that occur frequently during breast tumorigenesis. The major types of genetic abnormalities that are frequently observed in breast tumors are amplification of protooncogenes (MYC, ERBB2) and DNA from chromosome band 11q13; mutation of TP53; and loss of heterozygosity from chromosomes and chromosome arms 1, 3p, 6q, 7q, 8p, 11, 13q, 16q, 17, 18q, and 22q. The latter may correspond to losses or inactivations of tumor suppressor genes. Recently, linkage analyses of large families with a predisposition to breast cancer have been performed in order to map breast cancer susceptibility genes (TP53, BRCA1, BRCA2). The findings have thrown light on the molecular mechanisms of breast cancer and have enabled various genetic markers to be used in clinical oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., & King, M.-C. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,550
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
p53 Status and the Efficacy of Cancer Therapy in Vivo
Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., & Jacks, T. (1994) · Science · doi:10.1126/science.7973635 · Cited by 1,469
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993) · Europe PMC (PubMed Central) · Cited by 1,243
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
BRCA1 Mutations in Primary Breast and Ovarian Carcinomas
Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., et al. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,205
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Identification of Heregulin, a Specific Activator of p185 erbB2
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) · Science · doi:10.1126/science.256.5060.1205 · Cited by 962
c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer
Muss, H. B., Thor, A. D., Berry, D. A., Kute, T., Liu, E. T., Koerner, F., Cirrincione, C. T., Budman, D. R., Wood, W. C., Barcos, M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301802 · Cited by 961
Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells
Zou, Z., Anisowicz, A., Hendrix, M. J. C., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., & Sager, R. (1994) · Science · doi:10.1126/science.8290962 · Cited by 912
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes
Stewart, T. A., Pattengale, P. K., & Leder, P. (1984) · Cell · doi:10.1016/0092-8674(84)90257-5 · Cited by 899
Neu-Protein Overexpression in Breast Cancer
van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., & Nusse, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811103191902 · Cited by 860
Gusterson, B. A., Gelber, R. D., Goldhirsch, A., Price, K. N., Säve-Söderborgh, J., Anbazhagan, R., Styles, J., Rudenstam, C. M., Golouh, R., & Reed, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1049 · Cited by 838
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
Liu, B., Nicolaides, N. C., Markowitz, S., Willson, J. K. V., Parsons, R. E., Jen, J., Papadopolous, N., Peltomäki, P., de la Chapelle, A., Hamilton, S. R., et al. (1995) · Nature Genetics · doi:10.1038/ng0195-48 · Cited by 802
Lothe, R. A., Peltomäki, P., Meling, G., Aaltonen, L. A., Nyström, M., Pylkkänen, L., Heimdal, K., Andersen, T. I., Møller, P., & Rognum, T. O. (1993) · PubMed · Cited by 778
Antioncogenes and human cancer.
Knudson, A. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10914 · Cited by 762
Kallioniemi, A., Kallioniemi, O. P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W., & Waldman, F. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2156 · Cited by 739
Kraus, M. H., Issing, W., Miki, T., Popescu, N. C., & Aaronson, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9193 · Cited by 737
Thor, A. D., Moore, D. H., Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L.-C., Mayall, B. H., et al. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.11.845 · Cited by 723
Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., & Takeichi, M. (1993) · PubMed · Cited by 661
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 661
Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E., & King, M.-C. (1994) · Nature Genetics · doi:10.1038/ng1294-399 · Cited by 622
Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas.
Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M., & Abe, O. (1989) · PubMed · Cited by 596
Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., & Holt, J. T. (1995) · Nature Genetics · doi:10.1038/ng0495-444 · Cited by 585
HER-2/neu oncogene protein and prognosis in breast cancer.
Tandon, A. K., Clark, G. M., Chamness, G. C., Ullrich, A., & McGuire, W. L. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.8.1120 · Cited by 574
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., & Gray, J. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5321 · Cited by 555
Microsatellite instability: marker of a mutator phenotype in cancer.
Loeb, L. A. (1994) · PubMed · Cited by 546
Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B., & Yarden, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90131-u · Cited by 524
Postel, E. H., Berberich, S. J., Flint, S. J., & Ferrone, C. A. (1993) · Science · doi:10.1126/science.8392752 · Cited by 495
Ottaviano, Y. L., Issa, J. J., Parl, F. F., Smith, H. S., Baylin, S. B., & Davidson, N. E. (1994) · PubMed · Cited by 481
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families
Birch, Hartley, Tricker, Prosser, P., Condie, Kelsey, Harris, Jones, Binchy, Crowther, et al. (1994) · Cancer Research · Cited by 475
How many mutations are required for tumorigenesis? implications from human cancer data
Balmain, A., Barrett, J. C., Moses, H., & Renan, M. J. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940070303 · Cited by 464
Heregulin induces tyrosine phosphorylation of HER4/p180erbB4
Plowman, G. D., Green, J. M., Culouscou, J.-M., Carlton, G. W., Rothwell, V. M., & Buckley, S. (1993) · Nature · doi:10.1038/366473a0 · Cited by 441
Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p Loss
Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., & Sidransky, D. (1994) · Science · doi:10.1126/science.8023167 · Cited by 427
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
Birch, J. M., Hartley, A. L., Tricker, K. J., Prosser, J., Condie, A., Kelsey, A. M., Harris, M., Jones, P. H. M., Binchy, A., & Crowther, D. (1994) · PubMed · Cited by 421
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
Escot, C., Theillet, C., Lidereau, R., Spyratos, F., Champeme, M. H., Gest, J., & Callahan, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4834 · Cited by 412
Self-citationSmith, S. A., Easton, D. F., Evans, D. G. R., & Ponder, B. A. J. (1992) · Nature Genetics · doi:10.1038/ng1092-128 · Cited by 411
Instability of short tandem repeats (microsatellites) in human cancers
Wooster, R., Cleton-Jansen, A.-M., Collins, N., Mangion, J., Cornelis, R. S., Cooper, C. S., Gusterson, B. A., Ponder, B. A. J., von Deimling, A., Wiestler, O. D., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-152 · Cited by 404
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer
Castilla, L. H., Couch, F. J., Erdos, M. R., Hoskins, K. F., Calzone, K., Garber, J. E., Boyd, J., Lubin, M. B., Deshano, M. L., Brody, L. C., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-387 · Cited by 383
Varley, J. M., Swallow, J. E., Brammar, W. J., Whittaker, J. L., & Walker, R. A. (1987) · PubMed · Cited by 360
Cyclin E, a Potential Prognostic Marker in Breast Cancer.
Keyomarsi, K. (1997) · doi:10.21236/ada341275 · Cited by 344
van de Vijver, M., van de Bersselaar, R., Devilee, P., Cornelisse, C., Peterse, J., & Nusse, R. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.2019 · Cited by 330
Tumorigenicity in Human Melanoma Cell Lines Controlled by Introduction of Human Chromosome 6
Trent, J. M., Stanbridge, E. J., McBride, H. L., Meese, E. U., Casey, G., Araujo, D. E., Witkowski, C. M., & Nagle, R. B. (1990) · Science · doi:10.1126/science.2300817 · Cited by 326
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families
Simard, J., Tonin, P., Durocher, F., Morgan, K., Rommens, J., Gingras, S., Samson, C., Leblanc, J.-F., Bélanger, C., Dion, F., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-392 · Cited by 324
Schuuring, E., Verhoeven, E., Mooi, W. J., & Michalides, R. J. A. M. (1992) · PubMed · Cited by 317
Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
Easton, D., Bishop, D., Ford, D., Crockford, G., Haites, N., Milner, B. J., Allan, L., King, M., Bowcock, A. M., Anderson, L., et al. (1993) · UCL Discovery (University College London) · Cited by 309
Leone, A., Flatow, U., VanHoutte, K., & Steeg, P. S. (1993) · PubMed · Cited by 296
An Association between the Risk of Cancer and Mutations in the HRAS1 Minisatellite Locus
Krontiris, T. G., Devlin, B., Karp, D. D., Robert, N. J., & Risch, N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290801 · Cited by 287
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.
Fuqua, S. A. W., Sd, F., Allred, D. C., Elledge, R. M., Nawaz, Z., Dp, M., O’Malley, B. W., Greene, G., & Wl, M. (1992) · PubMed · Cited by 252
Wooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett-Lee, P., Easton, D. F., Ponder, B. A. J., & Stratton, M. R. (1992) · Nature Genetics · doi:10.1038/ng1092-132 · Cited by 250
Collins, N., McManus, R., Wooster, R., Mangion, J., Seal, S., Lakhani, S. R., Ormiston, W. J., Daly, P. A., Ford, D., & Easton, D. F. (1995) · PubMed · Cited by 243
Adnane, J., Gaudray, P., Ca, D., Crumley, G., Jaye, M., Schlessinger, J., Jeanteur, P., Birnbaum, D., & Theillet, C. G. (1991) · PubMed · Cited by 240
Genetic alterations in bladder cancer
Dalbagni, G., Presti, J., Fair, W. R., Reuter, V., & Cordon-Cardo, C. (1993) · The Lancet · doi:10.1016/0140-6736(93)91595-d · Cited by 238
Gasparini, G., Pozza, F., & Harris, A. L. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.15.1206 · Cited by 238
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types
Bianchi, A. B., Hara, T., Ramesh, V., Gao, J., Klein-Szanto, A. J. P., Morin, F., Menon, A. G., Trofatter, J. A., Gusella, J. F., Seizinger, B. R., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-185 · Cited by 230
Characterization of chromosomal anomalies in human breast cancer
Dutrillaux, B., Gerbault-Seureau, M., & Zafrani, B. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90143-x · Cited by 215
Catalog of Chromosome Aberrations in Cancer
Secker-Walker, L. M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.223 · Cited by 211
Oncogenic conversion by regulatory changes in transcription factors
Lewin, B. (1991) · Cell · doi:10.1016/0092-8674(91)90640-k · Cited by 210
Varley, J. M., Armour, J. A. L., Je, S., Jeffreys, A. J., Ponder, B. A., Tang, A. J., Fung, Y. K., Brammar, W. J., & Ra, W. (1989) · PubMed · Cited by 202
Berns, E., Klijn, J. G. M., van Putten, W. L., van Staveren, I. L., Portengen, H., & Foekens, J. A. (1992) · PubMed · Cited by 201
Devilee, P., van den Broek, M., Kuipers-Dukshoorn, N., Kolluri, R., Khan, P. M., Pearson, P. L., & Cornelisse, C. J. (1989) · Genomics · doi:10.1016/0888-7543(89)90023-2 · Cited by 195
Schuuring, E., Verhoeven, E., van Tinteren, H., Peterse, J. L., Boeser‐Nunnink, B., Thunnissen, E., Devilee, P., Cj, C., van de Vijver, M. J., & Mooi, W. J. (1992) · PubMed · Cited by 189
ERBB2 amplification in breast cancer with a high rate of proliferation.
Borg, Å., Baldetorp, B., Fernö, M., Killander, D., Olsson, H. L., & Sigurdsson, H. (1991) · PubMed · Cited by 188
Microsatellite instability and loss of heterozygosity in breast cancer.
Yee, C. J., Roodi, N., Verrier, C. S., & Parl, F. F. (1994) · PubMed · Cited by 186
Tanner, M., Tirkkonen, M., Kallioniemi, A. H., Collins, C. C., Stokke, T., Karhu, R., Kowbel, D., Shadravan, F., Hintz, M. F., & Kuo, W. L. (1994) · PubMed · Cited by 181
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
Dougall, W. C., Qian, X., Peterson, N. C., Miller, M. J., Samanta, A., & Greene, M. I. (1994) · PubMed · Cited by 180
Tumor Cell Growth Arrest Caused by Subchromosomal Transferable DNA Fragments from Chromosome 11
Koi, M., Johnson, L. A., Kalikin, L. M., Little, P. F. R., Nakamura, Y., & Feinberg, A. P. (1993) · Science · doi:10.1126/science.8469989 · Cited by 176
Amplification of the int-2 gene in primary human breast tumors.
Lidereau, R., Callahan, R., Dickson, C., Peters, G., Escot, C., & Ali, I. (1988) · PubMed · Cited by 168
Self-citationp53 mutations occur in aggressive breast cancer.
Mazars, R., Spinardi, L., BenCheikh, M., Simony-Lafontaine, J., Jeanteur, P., & Theillet, C. G. (1992) · PubMed · Cited by 156
Bouchet, C., Spyratos, F., Martin, P., Hacène, K., Gentile, A., & Oglobine, J. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.74 · Cited by 156
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q
Stratton, M. R., Ford, D., Neuhasen, S., Seal, S., Wooster, R., Friedman, L. S., King, M., Egilsson, V., Devilee, P., McManus, R., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-103 · Cited by 156
Howlett, A. R., PETERSEN, O. W., Bissell, M. J., & Steeg, P. S. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.24.1838 · Cited by 154
Water-soluble vitamin K in the newborn.
Rr, G. (1949) · PubMed · Cited by 154
Proto-oncogene amplification and human breast tumor phenotype
Adnane, J., Gaudray, P., Simon, M., Simony-Lafontaine, J., Jeanteur, P., & Theillet, C. G. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90028-5 · Cited by 151
Thompson, A. M., Anderson, T. J., Condie, A., Prosser, J., Chetty, U., Carter, D. C., Evans, H. J., & Steel, C. M. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500405 · Cited by 147
Guan, X., Meltzer, P. S., Dalton, W. S., & Trent, J. M. (1994) · Nature Genetics · doi:10.1038/ng1094-155 · Cited by 146
Kerangueven, F., Essioux, L., Dib, A., Noguchi, T., Allione, F., Geneix, J., Longy, M., Lidereau, R., Eisinger, F., & Pébusque, M. (1995) · PubMed · Cited by 132
Self-citationShackleford, G. M., MacArthur, C. A., Kwan, H. C. K., & VARMUS, H. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.740 · Cited by 131
Loss of heterozygosity and p53 gene mutations in breast cancer.
Deng, G., Chen, L. C., Schott, D. R., Thor, A. D., Bhargava, V., Ljung, B., Chew, K., & Smith, H. S. (1994) · PubMed · Cited by 124
Cropp, C. S., Lidereau, R., Campbell, G., Champene, M. H., & Callahan, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7737 · Cited by 123
Self-citationMuleris, M., Almeida, A., Gerbault‐Seureau, M., Malfoy, B., & Dutrillaux, B. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870100303 · Cited by 121
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
Lahoz, E. G., Xu, L., Schreiber‐Agus, N., & DePinho, R. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5503 · Cited by 119
Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease.
Zuppan, P., Hall, J., Lee, M. K., Ponglikitmongkol, M., & King, M. (1991) · PubMed · Cited by 113
Borg, Å., Zhang, Q. X., Alm, P., et al. (1992) · PubMed · Cited by 112
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.
Xu, L., Sgroi, D. C., Sterner, C. J., Beauchamp, R. L., Pinney, D., Keel, S. B., Ueki, K., Rutter, J. L., Buckler, A., & Louis, D. N. (1994) · PubMed · Cited by 108
Ductal carcinoma in-situ of the breast; second EORTC consensus meeting
van Dongen, J. A., Holland, R. D., Peterse, J. L., Fentiman, I., Lagios, M. D., Millis, R. R., & Recht, A. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80113-3 · Cited by 105
c‐myc amplification is an independent prognostic factor in postmenopausal breast cancer
Borg, Å., Baldetorp, B., Fernö, M., Olsson, H. L., & Sigurdsson, H. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510504 · Cited by 105
A genetic model of melanoma tumorigenesis based on allelic losses
Walker, G. J., Palmer, J. M., Walters, M. K., & Hayward, N. K. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870120208 · Cited by 103
Takita, K.-I., Sato, T., Miyagi, M., Watatani, M., Akiyama, F., Sakamoto, G., Kasumi, F., Abe, R., & Nakamura, Y. (1992) · PubMed · Cited by 98
Cyclin E, A Potential Prognostic Marker in Breast Cancer
Keyomarsi, K. (1998) · Defense Technical Information Center (DTIC) · doi:10.21236/ada368551 · Cited by 98
Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer
Karlseder, J., Zeillinger, R., Schneeberger, C., Czerwenka, K. F., Speiser, P., Kubista, E., Birnbaum, D., Gaudray, P., & Theillet, C. G. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870090108 · Cited by 96
p53 mutations and histological type of invasive breast carcinoma.
Marchetti, A., Buttitta, F., Pellegrini, S., Campani, D., Diella, F., Cecchetti, D., Callahan, R., & Bistocchi, M. (1993) · PubMed · Cited by 96
Male breast cancer and the androgen receptor gene
Lobaccaro, J. A., Lumbroso, S., Belon, C., Galtier, F., Bringer, J., Lesimple, T., Héron, J., Pujol, H., & Sultan, C. (1993) · Nature Genetics · doi:10.1038/ng1093-109 · Cited by 95
Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer
Thompson, A., Morris, R., Wallace, M., Wyllie, A. H., Steel, C. M., & Carter, D. C. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.287 · Cited by 90
Cornelis, R. S., van Vliet, M., Vos, C. B. J., Cleton-Jansen, A. M., van de Vijver, M. J., Peterse, J. L., Khan, P. M., Børresen‐Dale, A., Cj, C., & Devilee, P. (1994) · PubMed · Cited by 87
Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11.
Rinker-Schaeffer, C. W., Hawkins, A. L., Ru, N., Dong, J., Stoica, G., Griffin, C. A., Ichikawa, T., Barrett, J. C., & Isaacs, J. T. (1994) · PubMed · Cited by 86
Watson, P. H., Safneck, J. R., Le, K., Dubik, D., & Shiu, R. P. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.902 · Cited by 85
Frequent p53 gene mutations and novel alleles in familial breast cancer.
Glebov, O. K., McKenzie, K. E., White, C. A., & Sukumar, S. V. (1994) · PubMed · Cited by 82
Genetic changes in epithelial solid neoplasia.
Rodrı́guez, E., Sreekantaiah, C., & Chaganti, R. S. K. (1994) · PubMed · Cited by 81
Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus.
Enomoto, H., Ozaki, T., Takahashi, E., Nomura, N., Tabata, S., Takahashi, H., Ohnuma, N., Tanabe, M., Iwai, J., & Yoshida, H. (1994) · PubMed · Cited by 79
Evidence for multiple pathways to cellular senescence.
Sasaki, M., Honda, T., Yamada, H., Wake, N., Barrett, J. C., & Oshimura, M. (1994) · PubMed · Cited by 77
Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.
Winqvist, R., Mannermaa, A., Alavaikko, M. J., Blanco, G. A. C., Taskinen, P. J., Kiviniemi, H., Newsham, I., & Cavenee, W. K. (1993) · PubMed · Cited by 67
MDM2 gene amplification in human breast cancer
Quesnel, B., Preudhomme, C., Fournier, J., Fenaux, P., & Peyrat, J. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90128-7 · Cited by 67
Prognostic factors and response to therapy in breast cancer.
Klijn, J. G. M., Berns, E., & Foekens, J. A. (1993) · PubMed · Cited by 62
Two‐color FISH characterization of i(1q) and der(1;16) in human breast cancer cells
Kokalj-Vokač, N., Alemeida, A., Gerbault‐Seureau, M., et al. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070103 · Cited by 61
Loss and gain of distinct regions of chromosome 1q in primary breast cancer.
Bièche, I., Champème, M. H., & Lidereau, R. (1995) · PubMed · Cited by 61
Self-citationCornelis, R. S., Devilee, P., van Vliet, M., Kuipers‐Dijkshoorn, N. J., Kersenmaeker, A., Bardoel, A. F. J., Khan, P., & Cj, C. (1993) · PubMed · Cited by 58
The insulin‐like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer
Almeida, A., Muleris, M., Dutrillaux, B., & Malfoy, B. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110110 · Cited by 56
Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
Negrini, M., Sabbioni, S., Haldar, S., Possati, L., Castagnoli, A., Corallini, A., Bròdano, G. B., & Croce, C. M. (1994) · PubMed · Cited by 55
Predisposition for breast cancer in carriers of constitutional translocation 11q;22q.
Lindblom, A., Sandelin, K., Iselius, L., Dumanski, J. P., White, I. E., Nordenskjöld, M., & Larsson, C. (1994) · PubMed Central · Cited by 54
Abeln, E. C. A., Corver, W. E., Kuipers‐Dijkshoorn, N. J., Fleuren, G.-J., & Cornelisse, C. J. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.289 · Cited by 53
Adams, S. M., Helps, N. R., Sharp, M. G. F., Brammar, W. J., Walker, R. A., & Varley, J. M. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.2.91 · Cited by 50
Loss of heterozygosity in familial breast carcinomas.
Lindblom, A., Skoog, L. K., Rotstein, S., Werelius, B., Larsson, C., & Nordenskjöld, M. (1993) · PubMed · Cited by 50
Proto‐oncogene amplification and homogeneously staining regions in human breast carcinomas
Saint‐Ruf, C., Gerbault‐Seureau, M., Viégas-Pèquignot, E., Sigal‐Zafrani, B., Cassingena, R., & Dutrillaux, B. (1990) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870020105 · Cited by 49
Oncogenes and human breast cancer.
Hall, J., Zuppan, P., Anderson, L. A., Huey, B., Carter, C., & King, M. (1989) · PubMed · Cited by 48
Estrogen and progestin effects in human breast carcinogenesis
King, R. J. B. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00683189 · Cited by 46
A candidate tumor suppressor gene in human breast cancers.
Schott, D. R., Chang, J. N., Deng, G., Kurisu, W., Kuo, W., Gray, J. W., & Smith, H. S. (1994) · PubMed · Cited by 44
11q13 Amplification in local recurrence of human primary breast cancer
Champème, M. H., Bièche, I., Lizard, S., & Lidereau, R. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870120207 · Cited by 43
Self-citationBonsing, B. A., Devilee, P., Cleton-Jansen, A., Kuipers‐Dijkshoorn, N. J., Fleuren, G. J., & Cornelisse, C. J. (1993) · PubMed · Cited by 42
Amplification of the 11q13 region in human carcinoma cell lines: A mechanistic view
Roelofs, H., Schuuring, E. M. D., Wiegant, J. C. A. G., Michalides, R. J. A. M., & Giphart-Gassler, M. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070203 · Cited by 33
Chronic myelomonocytic leukemia with t(13;14) in a child
Bown, N. P., Yule, S. M., Evans, J., Kernahan, J., & Reid, M. M. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90016-2 · Cited by 21
Lebeau, J., Gerbault‐Seureau, M., Lemieux, N., Apiou, F., Calvo, F. M., Berthon, P., Goubin, G., & Dutrillaux, B. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600219 · Cited by 16
Somatic allele loss in genetic linkage analysis of cancer
Rebbeck, T. R., Lustbader, E. D., & Buetow, K. H. (1994) · Genetic Epidemiology · doi:10.1002/gepi.1370110504 · Cited by 11
Cited by
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Epidermal growth factor receptor: Mechanisms of activation and signalling
Jorissen, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00098-8 · Cited by 1,565
Lin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., & Pollard, J. W. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63568-7 · Cited by 1,107
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100566997 · Cited by 444
Metadata
- Authors
- Bièche, I., & Lidereau, R.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 1995-12
- Volume
- 14
- Issue
- 4
- Pages
- 227-251
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2025047211
- Cited by
- 303
- References
- 136
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.